Nebulized dehydroepiandrosterone-3-sulfate improves asthma control in the moderate-to-severe asthma results of a 6-week, randomized, double-blind, placebo-controlled study

Allergy and Asthma Proceedings

Volumn 31, Issue 6, 2010, Pages 461-471

  Wenzel, Sally E ^a   Robinson, Cynthia B ^b   Leonard, Joanne M ^b   Panettieri Jr , Reynold A ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Epigenesis Pharmaceuticals   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO; PRASTERONE SULFATE;

ADULT; AGED; ARTICLE; ASTHMA; BACKACHE; COUGHING; DISEASE CONTROL; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSGEUSIA; FEMALE; FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEBULIZER; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SORE THROAT; STATISTICAL SIGNIFICANCE; UPPER RESPIRATORY TRACT INFECTION;

ADRENERGIC BETA-AGONISTS; ADULT; ANDROSTADIENES; ASTHMA; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS;

EID: 78650494941     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3384     Document Type: Article

References (17)

1. Trends in Asthma Morbidity and Mortality. Available online at www.lungusa.org/atf/cf/{7A8D42C2-FCCA-4604-8ADE7F5D5E762256}/ASTHMA1.PDF; last accessed July 13, 2009.
2. Bateman ED, Homer A, Boushey JB, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med 170:836-844, 2004.
3. National Asthma Education and Prevention Program (NAEPP). Expert panel report 3. Available online at www.nhlbi.nih.gov/guidelines/asthma/index.html; last accessed July 13, 2009.
4. The Global Initiative for Asthma. GINA Report, Global strategy for asthma management and prevention. Available online at www.ginasthma.com/Guidelineitem; last accessed July 13, 2009.
5. Holgate ST, Holloway J, Wilson S, et al. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J Allergy Clin Immunol 117:496-506, 2006.
6. Wenzel SE, Szefler SJ, Leung DY, et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156:737-743, 1997.
7. Dolovich MA, MacIntyre NR, Anderson PJ, et al. Consensus statement on aerosols and delivery devices. Respir Care 45:588-596, 2000.
8. Waldrep JC, and Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv 5:114-119, 2008.
9. Juniper EF, O'Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 14:902-907, 1999.
10. Juniper EF, Buist AS, Cox FM, et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 115:1265-1270, 1999.
11. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 26:948-968, 2005.
12. Kendall M, and Stuart A. The Advanced Theory of Statistics, vol. 2, New York: MacMillan Publishing Co., Inc., 580-585, 1979.
13. Juniper EF, Bousquet J, Abetz L, and Bateman ED. Identifying "well-controlled" and "not well-controlled" asthma using the Asthma Control Questionnaire. Respir Med 100:616-621, 2006.
14. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119:405-413, 2007.
15. Wenzel SE, Barnes PJ, Bleecker ER, E et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factoralpha blockade in severe persistent asthma. Am J Respir Crit Care Med 179:549-558, 2009.
16. Kaiser J. Medical officer's efficacy review. Omalizumab summary basis of approval. Available online at www.fda.gov/downloads/Drugs/ DevelopmentApprovalProcess/HowDrugs areDevelopedandApproved/ ApprovalApplications/TherapeuticBiologicApplicatio ns/ucm11349.pdf; last accessed July 13, 2009.
17. Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: A multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 181:116-124, 2010.